Effect of M-cholinoblockers on the Clinical Course of Urinary Incontinence in Patients with an Artifical Bladder
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The objective: to study the M-cholinoblockers effect by urinary incontinence after the formation of an artificial bladder and to analyze the effectiveness of pharmacological correction on survival and quality of life.
Materials and methods. 114 patients after radical cystectomy with the formation of a neobladder at various stages of the postoperative period involved in the study. The significant urinary incontinence of different degrees, which affected the patient’s quality of life, was determined in 27 (23.7%) persons who were included in solifenacin effect study group.
To identify the degree of severity and the dynamics of recovery of the continence function, a questionnaire was conducted among patients who had urinary incontinence during the day and at night. With the help of a comprehensive study on the Delphis KT urodynamic unit, an analysis of urodynamic parameters in urinary incontinence was carried out.
Results. After the formation of an artificial bladder, the patients had more stable daytime continence due to mental control over urination and understanding the need to urinate according to time.
The situation was more complicated in patients with nocturnal urinary incontinence after radical cystectomy and the formation of an artificial bladder. However, after 2 weeks of treatment with solifenacin, patients had a significant improvement in the function of nocturnal urinary retention. After treatment with solifenacin patients had an improvement in daytime urinary retention by 37.2 % and nighttime urinary retention by 48.9 %.
Two-week treatment with solifenacin significantly improved the patient’s quality of life and the dynamics of enterocystomanometry indicators, as evidenced by the results of control studies. The indicator of the subjective sensitivity level increased statistically significantly by 35.24 % compared to the group before treatment and amounted to 304.2±62.1 cm of water column (p≤0.05). The level of the first urge to urinate also increased reliably by 20.4 % – 458.2±81.0 cm of water column (p≤0.05). The level of urge to urinate was 636.1±92.8 ml (p≤0.05), which was statistically significantly higher by 17.5 % compared to patients who did not take solifenacin.
Conclusions. The use of M-cholinoblockers in the correction of urinary incontinence in patients with an artificial urinary bladder due to the action on the smooth muscles of the intestines through parasympathetic innervation improves urodynamic indicators and the quality of life of the patients.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Richters A, Aben KKH, Lambertus AL, Kiemeney M. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895–904. doi: 10.1007/s00345-019-02984-4.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A. Cancer J Clin. 2021;71(3):209–49. doi:10.3322/caac.21660.
Pasyechnikov SP, Vozianov SO, Lisovyy VM. et al. Urolohiya: pidruchnyk dlya studentiv vyshchykh medychnykh navchal’nykh zakladiv IY rivnya akredytatsiyi: vyd. 2-he, vypr. I dopovn. Vinnytsya: Nova knyha; 2015. 432 p.
Saydakova NO, Shulyak OV, Dmytryshyn SP, Yatsyna OI, Shylo VM, Melnychuk YAM, ta in. Zahalna kartyna stanu urolohichnoyi sluzhby, osnovnykh pokaznykiv diyal’nosti, epidemiolohichnykh protsesiv v Ukrayini (2016–2017 roky). Urol. 2018;3:28–36.
Fedorenko Z, Michailovich Yu, Goulak L, Gorokh Ye, Ryzhov A, Soumkina O, Koutsenko L. Cancer in Ukraine 2019–2020: Incidence, mortality, prevalence and other relevant statistics. Kyiv: NCRU; 2021. 84 p.
Saydakova NO, Yatsyna OI, Hrodzinskyy VI, Stus VP, Polion MYU, Shylo VM. Med perspektyvy. 2021;26(2):173–80.
Vozianov SA, Shamrayev SN, Stus VN, Krasnov VN, Vasilyeva VD, Polion NYU, i dr. Dinamika pokazateley rannikh i otdalennykh rezul’tatov radikal’noy tsistektomii v zavisimosti ot perioda vypolneniya s 2005 po 2016 gody. Zdorovye muzhchiny. 2016;3:23–8.
Stakhovskyy EO, Yatsyna OI, Voylenko OA, Vitruk YUV, Stakhovskyy OE, Vikarchuk MV, ta in. Yakist zhyttya patsiyentiv pislya tsystektomiyi z ileoneoplastykoyu. V: Materil nauk.-prakt. konf. Dosyahnennya ta perspektyvy v onkourolohiyi, plastychniy ta rekonstruktyvniy khirurhiyi sechovyvidnykh shlyakhiv; 2013 Kvit. 18-20; Kyiv. Kyiv. Klyn onkolohyya. 2013, p. 42.
Mrachkovskiy VV, Kondratenko AV, Yakovlev PG, Sakalo VS, Kuranov YUYU, Sakalo AV, ta ín. Sobstvennyy opyt ortotopicheskoy intestinalnoy plastiki u 91 bolnogo rakom mochevogo puzyrya. Urol. 2009;11(1):51–4.
Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: The 90-day complication rate. J Urol. 2010;184(3):990–94. quiz 1235. doi: 10.1016/j.juro.2010.05.037.
Koraitim MM, Atta MA, Foda MK. Orthotopic bladder substitution in men revisited: identification of continence predictors. J Urol. 2006;176(5):2081–4. doi: 10.1016/j.juro.2006.07.006.
Hugonnet CL, Danuser H, Springer J, Studer UE. Urethral sensitivity and the impact on urinary continence in patients with an ileal bladder substitute after cystectomy. J Urol. 2001;165(5):1502–5.
Chen Z, Lu G, Li X, Li X, Fang Q, Ji H, et al. Better compliance contributes to better nocturnal continence with orthotopic ileal neobladder than ileocolonic neobladder after radical cystectomy for bladder cancer. Urol. 2009;73(4):838–43. doi: 10.1016/j.urology.2008.09.076.
Kessler TM, Burkhard FC, Perimenis P, Danuser H, Thalmann GN, Hochreiter WW, et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol. 2004;172(4 Pt 1):1323–7.
Carlson AB, Kraus GP. Physiology, Cholinergic Receptors [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526134/
Haga T. Molecular properties of muscarinic acetylcholine receptors. Proc Jpn Acad Ser B Phys Biol Sci. 2013;89(6):226–56. doi: 10.2183/pjab.89.226.
Savchuk RV, Kostyev FI, Shmatkova NV. Mozhlyvosti farmakolohichnoyi korektsiyi skorotlyvoyi aktyvnosti artyfitsiynoho sechovoho mikhura v eksperymentalnykh umovakh in vivo. Med perspektyvy. 2019;24(4):19–24. doi: 10.26641/2307-0404.2019.4.189182.
Thüroff JW, Mattiasson A, Andersen JT, Hedlund H, Hinman F Jr, Hohenfellner M, et al. The standardization of terminology and assessment of functional characteristics of intestinal urinary reservoirs. BJU Int. 1996;78(4):516–23. doi: 10.1046/j.1464-410x.1996.01394.x.
Månsson W, Hedlund H, Andersson KE. Effect of atropine and terbutaline on motor activity of the continent caecal reservoir for urine. Br J Urol. 1989;63(4):3758. doi: 10.1111/j.1464-410x.1989.tb05221.x.
Tonini M, Rizzi CA, Perncca E, De Ponti F, D’Angelo L, Del Vecchio A, et al. Depressant action of oxybutinin on the contractility of intestinal and urinary tract smooth muscle. J Pharm Pharmacol. 1987;39(2):1037. doi: 10.1111/j.2042-7158.1987.tb06953.x.
Sheldon CA, Reedes D, Lewis AG. Oxybutinin administration diminishes the high gastric muscular tone associated with bladder reconstruction. J Urol. 1995;153(2):4612. doi: 10.1097/00005392-199502000-00057.
Moroni RM, Magnani PS, Haddad JM, de Aquino Castro R, Oliveira Brito LG. Conservative treatment of stress urinary incontinence: A systematic review with metaanalysis of randomized controlled trials. Rev Bras Ginecol Obstet. 2016;38(2):97–111. doi: 10.1055/s-0035-1571252.
Singh V, Yadav R, Sinha RJ, Gupta DK. Prospective comparison of quality-of-life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: A statistical model. BJU Int. 2014;113(5):726–32. doi: 10.1111/bju.12440.
Kessler TM, Burkhard FC, Perimenis P, Danuser H, Thalmann GN, Hochreiter WW, et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol. 2004;172:(4Pt1):1323–7. doi: 10.1097/01.ju.0000138249.31644.ec.
